| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $401K | +175.0% |
| Cost of Revenue | $28K | — |
| Gross Profit | $373K | +155.8% |
| R&D Expense | $5.3M | +32.6% |
| SG&A Expense | $6.6M | -41.9% |
| Operating Income | -$11.6M | +24.1% |
| Net Income | -$9.0M | +37.7% |
| EPS (Basic) | -$1.16 | +66.1% |
| EPS (Diluted) | -$1.16 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $548K | -38.0% |
| Short-term Investments | $10.2M | +0.0% |
| Accounts Receivable | $188K | +876.2% |
| Current Assets | $11.1M | -2.2% |
| Total Assets | $12.3M | -2.6% |
| Current Liabilities | $3.7M | +252.5% |
| Total Liabilities | $3.7M | +252.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.2M | -28.0% |
| Capital Expenditures | $106K | -37.9% |
| Investing Cash Flow | $515K | -84.2% |
| Financing Cash Flow | $7.4M | +213.8% |
| Free Cash Flow | -$8.3M | -26.3% |
| +66.1% |
| Stockholders' Equity |
| $8.5M |
| -26.1% |